Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 21, 2004
Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel nodeAlistair J Cochran, Duan-Ren Wen, Rong-Rong Huang, et al.
Respiratory Research|August 17, 2012
Comparison of the variability of the annual rates of change in FEV₁ determined from serial measurements of the pre- versus post-bronchodilator FEV₁ over 5 years in mild to moderate COPD: results of the lung health studyDonald P Tashkin, He-Jing Wang, David Halpin, et al.
JAMA Neurology|June 14, 2016
Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple SclerosisAllan MacKenzie-Graham, Florian Kurth, Yuichiro Itoh, et al.
Cancer|June 16, 2010
Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatmentHelena R Chang, John Glaspy, Mary Ann Allison, et al.
International Journal of Oncology|August 9, 2002
Inhibition of fibroblast growth factors by green teaMaryam R Sartippour, David Heber, Liping Zhang, et al.
The Breast Journal|July 9, 2003
The use of oxytocin in nipple fluid aspirationLiping Zhang, Zhi-Ming Shao, Perrin Beatty, et al.
The Journal of Rheumatology|March 17, 2009
Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with sclerodermaFaye N Hant, Anna Ludwicka-Bradley, He-Jing Wang, et al.
International Journal of Oncology|June 18, 2004
cDNA microarray analysis of endothelial cells in response to green tea reveals a suppressive phenotypeMaryam R Sartippour, David Heber, Susanne Henning, et al.
Kidney International|September 24, 2010
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidismKatherine Wesseling-Perry, Renata C Pereira, Shobha Sahney, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 6, 2013
The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trialJustine Bacchetta, Katherine Wesseling-Perry, Beatriz Kuizon, et al.
Pageof 8